Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Helicobacter Eradication to Prevent Ulcer Bleeding in Aspirin Users: a Large Simple Randomised Controlled Trial

NCT01506986 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.

NCT NCT01506986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01506986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Helicobacter Eradication to Prevent Ulcer Bleeding in Aspirin Users: a Large Simple Randomised Controlled Trial
Lead sponsor
University of Nottingham
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2012
Completion date
March 16, 2022
Enrollment
30,024 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial infection due to helicobacter pylori (h. pylori), gastrointestinal ulcer haemorrhage